190 related articles for article (PubMed ID: 14517187)
1. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies.
Morgan B; Thomas AL; Drevs J; Hennig J; Buchert M; Jivan A; Horsfield MA; Mross K; Ball HA; Lee L; Mietlowski W; Fuxuis S; Unger C; O'Byrne K; Henry A; Cherryman GR; Laurent D; Dugan M; Marmé D; Steward WP
J Clin Oncol; 2003 Nov; 21(21):3955-64. PubMed ID: 14517187
[TBL] [Abstract][Full Text] [Related]
2. Combined inhibitors of angiogenesis and histone deacetylase: efficacy in rat hepatoma.
Ganslmayer M; Zimmermann A; Zopf S; Herold C
World J Gastroenterol; 2011 Aug; 17(31):3623-9. PubMed ID: 21987609
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic therapy with contrast-enhanced ultrasound in colorectal cancer patients with liver metastasis.
Wu Z; Yang X; Chen L; Wang Z; Shi Y; Mao H; Dai G; Yu X
Medicine (Baltimore); 2017 May; 96(20):e6731. PubMed ID: 28514289
[TBL] [Abstract][Full Text] [Related]
4. Mixed-effects modeling of clinical DCE-MRI data: application to colorectal liver metastases treated with bevacizumab.
Ferl GZ; O'Connor JP; Parker GJ; Carano RA; Acharya SJ; Jayson GC; Port RE
J Magn Reson Imaging; 2015 Jan; 41(1):132-41. PubMed ID: 24753433
[TBL] [Abstract][Full Text] [Related]
5. Phase I evaluation of CDP791, a PEGylated di-Fab' conjugate that binds vascular endothelial growth factor receptor 2.
Ton NC; Parker GJ; Jackson A; Mullamitha S; Buonaccorsi GA; Roberts C; Watson Y; Davies K; Cheung S; Hope L; Power F; Lawrance J; Valle J; Saunders M; Felix R; Soranson JA; Rolfe L; Zinkewich-Peotti K; Jayson GC
Clin Cancer Res; 2007 Dec; 13(23):7113-8. PubMed ID: 18056191
[TBL] [Abstract][Full Text] [Related]
6. DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study.
Mross K; Fasol U; Frost A; Benkelmann R; Kuhlmann J; Büchert M; Unger C; Blum H; Hennig J; Milenkova TP; Tessier J; Krebs AD; Ryan AJ; Fischer R
J Angiogenes Res; 2009 Sep; 1():5. PubMed ID: 19946413
[TBL] [Abstract][Full Text] [Related]
7. MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients.
Mo T; Brandal SHB; Geier OM; Engebråten O; Nilsen LB; Kristensen VN; Hole KH; Hompland T; Fleischer T; Seierstad T
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760629
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric MRI for characterization of the tumour microenvironment.
Hoffmann E; Masthoff M; Kunz WG; Seidensticker M; Bobe S; Gerwing M; Berdel WE; Schliemann C; Faber C; Wildgruber M
Nat Rev Clin Oncol; 2024 Jun; 21(6):428-448. PubMed ID: 38641651
[TBL] [Abstract][Full Text] [Related]
9. Scintigraphic Imaging of Neovascularization With
Jin X; Dong C; Zheng K; Shi X; Liu Y; Huo L; Wang F; Li F
Front Oncol; 2021; 11():792431. PubMed ID: 35769548
[TBL] [Abstract][Full Text] [Related]
10. CFO: Calibration-free odds design for phase I/II clinical trials.
Jin H; Yin G
Stat Methods Med Res; 2022 Jun; 31(6):1051-1066. PubMed ID: 35238697
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Imaging Characterization of Colorectal Liver Metastases.
Maclean D; Tsakok M; Gleeson F; Breen DJ; Goldin R; Primrose J; Harris A; Franklin J
Front Oncol; 2021; 11():730854. PubMed ID: 34950575
[TBL] [Abstract][Full Text] [Related]
12. Blood-Brain Barrier Repair of Bevacizumab and Corticosteroid as Prediction of Clinical Improvement and Relapse Risk in Radiation-Induced Brain Necrosis: A Retrospective Observational Study.
Xue R; Chen M; Cai J; Deng Z; Pan D; Liu X; Li Y; Rong X; Li H; Xu Y; Shen Q; Tang Y
Front Oncol; 2021; 11():720417. PubMed ID: 34692494
[TBL] [Abstract][Full Text] [Related]
13. Correlation of radiomic features on dynamic contrast-enhanced magnetic resonance with microvessel density in hepatocellular carcinoma based on different models.
Liang H; Hu C; Lu J; Zhang T; Jiang J; Ding D; Du S; Duan S
J Int Med Res; 2021 Mar; 49(3):300060521997586. PubMed ID: 33682491
[TBL] [Abstract][Full Text] [Related]
14. A Bayesian adaptive phase I/II clinical trial design with late-onset competing risk outcomes.
Zhang Y; Cao S; Zhang C; Jin IH; Zang Y
Biometrics; 2021 Sep; 77(3):796-808. PubMed ID: 32735346
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors.
Zhu M; Molina JR; Dy GK; Croghan GA; Qi Y; Glockner J; Hanson LJ; Roos MM; Tan AD; Adjei AA
Invest New Drugs; 2020 Dec; 38(6):1755-1762. PubMed ID: 32328844
[TBL] [Abstract][Full Text] [Related]
16. Topics on quantitative liver magnetic resonance imaging.
Wáng YXJ; Wang X; Wu P; Wang Y; Chen W; Chen H; Li J
Quant Imaging Med Surg; 2019 Nov; 9(11):1840-1890. PubMed ID: 31867237
[TBL] [Abstract][Full Text] [Related]
17. Early Changes in CT Perfusion Parameters: Primary Renal Carcinoma Versus Metastases After Treatment with Targeted Therapy.
Fan AC; Sundaram V; Kino A; Schmiedeskamp H; Metzner TJ; Kamaya A
Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31052289
[TBL] [Abstract][Full Text] [Related]
18. An information theoretic phase I-II design for molecularly targeted agents that does not require an assumption of monotonicity.
Mozgunov P; Jaki T
J R Stat Soc Ser C Appl Stat; 2019 Feb; 68(2):347-367. PubMed ID: 31007292
[TBL] [Abstract][Full Text] [Related]
19. Novel biomarkers for patient stratification in colorectal cancer: A review of definitions, emerging concepts, and data.
Chand M; Keller DS; Mirnezami R; Bullock M; Bhangu A; Moran B; Tekkis PP; Brown G; Mirnezami A; Berho M
World J Gastrointest Oncol; 2018 Jul; 10(7):145-158. PubMed ID: 30079141
[TBL] [Abstract][Full Text] [Related]
20. A new preclinical ultrasound platform for widefield 3D imaging of rodents.
Czernuszewicz TJ; Papadopoulou V; Rojas JD; Rajamahendiran RM; Perdomo J; Butler J; Harlacher M; O'Connell G; Zukić D; Aylward SR; Dayton PA; Gessner RC
Rev Sci Instrum; 2018 Jul; 89(7):075107. PubMed ID: 30068108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
